Acorda Therapeutics reported $7.82M in Interest Expense on Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Amgen AMGN:US $ 281M 4M
Biogen BIIB:US $ 66.3M 9.9M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Cytokinetics CYTK:US $ 4.07M 0.08M
Gilead Sciences GILD:US $ 256M 1M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Halozyme Therapeutics HALO:US $ 1.75M 0.21M
Insmed INSM:US $ 10.32M 2.76M
Mannkind MNKD:US $ 3.18M 3.27M
Moderna Inc MRNA:US 5M 2M
Neurocrine Biosciences NBIX:US $ 6.2M 0.2M
Novartis NOVN:VX 201M 1000K
Pfizer PFE:US $ 316M 20M
Teva Pharmaceutical TEVA:IT 240M 1000K
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M